Agreed; this is partly why I've asked Dr. Ziering whether the upcoming trial of H.S.C. will comprise subjects who show roughly a Norwood-VI class of baldness — I hope he answers.
I'm not sure what you mean, then, by advocating "early release." If the product passes safety and efficacy trials, of course it will come to market (barring an unforeseen problem getting it released). Until and unless that happens, it should not.
I'm not sure what you mean, then, by advocating "early release." If the product passes safety and efficacy trials, of course it will come to market (barring an unforeseen problem getting it released). Until and unless that happens, it should not.
Comment